About us – Scientific Advisors

J.S. Dileep Kumar, Ph.D.
Dr. Dileep Kumar is a Principal Investigator at Columbia University, Department of Psychiatry, Division of Molecular Imaging and Neuropathology.  He also holds an appointment in PET Chemistry at New York Psychiatric Institute.  His work in organic chemistry and radiochemistry currently focuses on short lived isotopes for use in human patients while his experience covers longer lived isotopes in research models.

S. John Gatley, Ph.D.
Dr. John Gatley (retired) is former Professor and Director of Graduate Programs at the Department of Pharmaceutical Sciences at Northeastern University.  He previously held at Brookhaven National Lab the positions of Chair of the Medical Department and of Senior Scientist in the radiopharmaceutical development program. Major aspects of this work involved research in medical radionuclide imaging, radio-pharmaceutical chemistry, biochemical pharmacology of radiopharmaceuticals, as well as neurochemistry and neuropharmacology of drugs of abuse in humans as well as animal models ranging from primates (baboons) to rodents.  Dr. Gatley’s work has included the design, synthesis and radiolabeling of candidate radiotracers for imaging receptors using positron emission tomography (PET) and single photon emission computed tomography (SPECT).
View Profile >>

Yasmin Hurd, Ph.D.
Dr. Yasmin Hurd received her Ph.D. from the Karolinska Institutet in Stockholm, Sweden in Neuropsychopharmacology. She currently holds the positions at the Ichan School of Medicine at Mount Sinai (New York, NY) of Chair in Translational Neuroscience and Professor in the Departments of Psychiatry, Pharmacology and Systems Therapeutics, and Neuroscience. She also serves on the Executive Committee of the Friedman Brain Institute. Dr. Hurd heads the Molecular Neuropsychopharmacology laboratory at Mount Sinai and her multidisciplinary research investigates the neurobiology underlying addiction disorders and related psychiatric illnesses in humans and in rodent disease models and is a pioneer in the development of applications such as microdialysis in freely-moving animals, and in situ hybridization and receptor autoradiography in the postmortem human brain.
View Profile >>

Michiko Miura Ph.D.
Dr. Michiko Miura received her Ph.D. in Organic Chemistry from the University of California Davis in 1984. She has worked for over two decades as a senior scientist designing and synthesizing new compounds for various cancer therapies and evaluating their in vivo properties and radiolabeling biomolecules for various types of imaging in the Medical Department at Brookhaven National Laboratory. Dr. Miura has significant research experience in chemistry, radiation biology, pharmacology and animal techniques.
View Profile>>